Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Jiangsu Nhwa Pharmaceutical Co Ltd
Revenue
Jiangsu Nhwa Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
|
Revenue
¥5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥10.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥23.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Revenue
¥561.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Nhwa Pharmaceutical Co Ltd's Revenue?
Revenue
5B
CNY
Based on the financial report for Dec 31, 2023, Jiangsu Nhwa Pharmaceutical Co Ltd's Revenue amounts to 5B CNY.
What is Jiangsu Nhwa Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Jiangsu Nhwa Pharmaceutical Co Ltd have been 14% over the past three years , 5% over the past five years , and 8% over the past ten years .